Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Systemic chemotherapy.

Klimek VM, Wolchok JD, Chapman PB, Houghton AN, Hwu WJ.

Clin Plast Surg. 2000 Jul;27(3):451-61, ix-x. Review.

PMID:
10941565
2.

Systemic chemotherapy in the treatment of malignant melanoma.

Lens MB, Eisen TG.

Expert Opin Pharmacother. 2003 Dec;4(12):2205-11. Review.

PMID:
14640919
3.

[Treatment of metastasized malignant melanoma].

Kamanabrou D.

Praxis (Bern 1994). 2001 Mar 8;90(10):391-6. Review. German.

PMID:
11305184
4.

Chemotherapy for advanced malignant melanoma.

Buzaid AC, Murren J.

Int J Clin Lab Res. 1992;21(3):205-9. Review.

PMID:
1591369
5.

Biochemotherapy of melanoma.

Flaherty LE, Gadgeel SM.

Semin Oncol. 2002 Oct;29(5):446-55. Review.

PMID:
12407509
7.

[Chemotherapy of malignant melanoma--current status].

Karg C, Garbe C, Orfanos CE.

Hautarzt. 1990 Feb;41(2):56-65. Review. German.

PMID:
2180855
8.

Current management of metastatic melanoma.

Trinh VA.

Am J Health Syst Pharm. 2008 Dec 15;65(24 Suppl 9):S3-8. doi: 10.2146/ajhp080460.

PMID:
19052264
9.

Combined chemoimmunotherapy in metastatic melanoma--is there a need for the double?

Schrader AJ.

Anticancer Drugs. 2000 Mar;11(3):143-8. Review.

PMID:
10831272
10.

The treatment of metastatic melanoma with chemotherapy and biologics.

Atkins MB.

Curr Opin Oncol. 1997 Mar;9(2):205-13. Review.

PMID:
9161801
11.

Systemic therapy in melanoma.

Nathan FE, Mastrangelo MJ.

Semin Surg Oncol. 1998 Jun;14(4):319-27. Review.

PMID:
9588725
12.

Interleukin-2 for the treatment of melanoma.

Tarhini AA, Agarwala SS.

Curr Opin Investig Drugs. 2005 Dec;6(12):1234-9. Review.

PMID:
16370388
13.

Treatments for metastatic melanoma: synthesis of evidence from randomized trials.

Lui P, Cashin R, Machado M, Hemels M, Corey-Lisle PK, Einarson TR.

Cancer Treat Rev. 2007 Dec;33(8):665-80. Epub 2007 Oct 4. Review.

PMID:
17919823
14.

Dacarbazine DTIC and carboplatin as an outpatient treatment for disseminated malignant melanoma.

Nieboer P, Mulder NH, Van Der Graaf WT, Willemse PH, Hospers GA.

Anticancer Res. 2001 Jul-Aug;21(4B):3115-6.

PMID:
11712820
15.

Chemotherapy for metastatic melanoma: time for a change?

Gogas HJ, Kirkwood JM, Sondak VK.

Cancer. 2007 Feb 1;109(3):455-64. Review.

17.

Randomized trial of dacarbazine versus bleomycin, vincristine, lomustine and dacarbazine (BOLD) chemotherapy combined with natural or recombinant interferon-alpha in patients with advanced melanoma.

Vuoristo MS, Hahka-Kemppinen M, Parvinen LM, Pyrhönen S, Seppä H, Korpela M, Kellokumpu-Lehtinen P.

Melanoma Res. 2005 Aug;15(4):291-6.

PMID:
16034308
18.

Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.

Minor DR, Moore D, Kim C, Kashani-Sabet M, Venna SS, Wang W, Boasberg P, O'Day S.

Oncologist. 2009 Oct;14(10):995-1002. doi: 10.1634/theoncologist.2009-0083. Epub 2009 Sep 23.

19.

Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival.

Bedikian AY, Johnson MM, Warneke CL, McIntyre S, Papadopoulos N, Hwu WJ, Kim K, Hwu P.

J Immunotoxicol. 2008 Apr;5(2):201-7. doi: 10.1080/15476910802131519.

PMID:
18569391
20.

Chemotherapy for metastatic melanoma.

Mandarà M, Nortilli R, Sava T, Cetto GL.

Expert Rev Anticancer Ther. 2006 Jan;6(1):121-30. Review.

PMID:
16375649

Supplemental Content

Support Center